PTC Therapeutics, Inc.

PTCTNASDAQUSD
71.10 USD
0.37 (0.51%)🟢LIVE (AS OF 11:01 AM EDT)
🟢Market: OPEN
Open?$71.45
High?$74.46
Low?$70.39
Prev. Close?$71.47
Volume?147.7K
Avg. Volume?1.3M
VWAP?$71.26
Rel. Volume?0.11x
Bid / Ask
Bid?$60.61 × 100
Ask?$81.55 × 100
Spread?$20.94
Midpoint?$71.08
Valuation & Ratios
Market Cap?5.9B
Shares Out?82.9M
Float?75.5M
Float %?94.1%
P/E Ratio?N/A
P/B Ratio?-32.85
EPS?-$2.25
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.
Employees
991
Market Cap
5.9B
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2013-06-20
Address
500 WARREN CORPORATE CENTER DRIVE
WARREN, NJ 07059
Phone: (908) 222-7000
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?2.44Strong
Quick Ratio?2.36Strong
Cash Ratio?0.90Adequate
Debt/Equity?-1.62Low
ValuationFAIRLY VALUED
Score
67/100
P/E?
N/A
P/B?
-32.85CHEAP
P/S?
7.17HIGH
P/FCF?
N/A
EV/EBITDA?
-279.1CHEAP
EV/Sales?
6.51HIGH
Returns & Efficiency
ROE?
103.5%STRONG
ROA?
-6.5%WEAK
Cash Flow & Enterprise
FCF?$-226282000
Enterprise Value?$5.4B
Fundamentals ratios updated end of day